PYPD - PolyPid Ltd.

4.43
-0.150   -3.386%

Share volume: 19,338
Last Updated: 04-28-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.05%

PREVIOUS CLOSE
CHG
CHG%
$4.58
-0.15
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
19%
Profitability 0%
Dept financing 23%
Liquidity 43%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.11%
1 Month
5.23%
3 Months
-5.94%
6 Months
16.58%
1 Year
69.08%
2 Year
-7.17%
Key data
Stock price
$4.43
P/E Ratio 
0.00
DAY RANGE
$4.35 - $4.59
EPS 
N/A
52 WEEK RANGE
$2.44 - $5.12
52 WEEK CHANGE
$55.44
MARKET CAP 
17.030 M
YIELD 
N/A
SHARES OUTSTANDING 
4.797 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.57
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$44,427
AVERAGE 30 VOLUME 
$57,801
Company detail
CEO: Dikla C. Akselbrad
Region: US
Website: polypid.com
Employees: 80
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs)

Recent news